表紙
市場調查報告書

生物相似藥市場分析、規模、佔有率、趨勢、預測 (2016 - 2027年) - COVID-19更新:各產品類型、用途、地區

Biosimilars Market, By Product Type, Application And Geography - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated

出版商 AnalystView Market Insights 商品編碼 950987
出版日期 內容資訊 英文 230 Pages
商品交期: 2-3個工作天內
價格
生物相似藥市場分析、規模、佔有率、趨勢、預測 (2016 - 2027年) - COVID-19更新:各產品類型、用途、地區 Biosimilars Market, By Product Type, Application And Geography - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated
出版日期: 2020年07月01日內容資訊: 英文 230 Pages
簡介

全球生物相似藥市場規模,2019年估計116億9000萬美元,在預測期間中預計以26.9%的成長率擴大。由於消費者的資產、所得水準的上升,政府、患者意識提高,及朝向健康的生活方式的趨勢,亞太地區的從2014年到2018年的期間中,醫療費約上升8.1%。生物相似藥需要高額的投資成本,進入市場前耗費7∼8年。經濟擴大及政府的廣泛福利政策的重視,預計牽引生物相似藥市場。

本報告提供全球生物相似藥市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

生物相似藥市場概要

  • 調查範圍
  • 基準年
  • 前提條件與調查手法

摘要整理

  • 主要市場資料
  • 地區方案
  • 市場參與企業

生物相似藥市場主要趨勢

  • 市場成長要素
  • 市場成長要素的影響分析
  • 阻礙市場要素
  • 阻礙市場要素的影響分析
  • 市場機會
  • 市場未來趨勢

生物相似藥市場調查

  • 開發平台治療分析
  • 價格分析
  • 大企業的新投入

生物相似藥 市場形勢

  • 市場佔有率分析
  • 主要創新者

生物相似藥市場:各產品類型:

  • 概要
  • 重組糖基化蛋白質
    • 概要
    • 市場分析、預測、與前一年同期比較成長率(以金額為準)
  • 重組的非糖基化蛋白質
  • 重組肽

生物相似藥市場:各應用領域:

  • 概要
  • 腫瘤學
    • 概要
    • 市場分析、預測、與前一年同期比較成長率(以金額為準)
  • 血液疾病
  • 感染疾病
  • 自體免疫疾病
  • 其他病

生物相似藥市場:各地區

  • 簡介
  • 北美
    • 概要
    • 市場分析、預測、與前一年同期比較成長率(以金額為準)
  • 美國
  • 加拿大
  • 歐洲
  • 法國
  • 德國
  • 其他歐洲
  • 亞太地區(APAC)
  • 中國
  • 印度
  • 亞太地區的其他各國
  • 其他地區
  • 南美
  • 中東和非洲

供應商分析

  • Astra Zeneca, plc
    • 公司概要
    • SWOT分析
    • 主要的發展
  • Amgen, Inc.
  • Pfizer, Inc.
  • Biocon Ltd.
  • Novartis AG
  • Teva Pharma
  • STADA AG

分析師全方位展望

附錄

目錄

Title:
Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated.

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the Biosimilars Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Biosimilars Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

KEY PREMIUM INSIGHTS:

  • Rising consumer wealth and income levels, increasing government and patient awareness, and a trend towards healthier lifestyles are anticipated to boost health care spending to around 8.1% in 2014-2018 in Asia Pacific
  • Biosimilars require high costs of investment and require a time frame to 7-8 years to enter the market
  • Economic expansion and government focus on broader welfare policies will drive the market for biosimilars.

REPORT HIGHLIGHT

The "Global Biosimilars Market- Industry Analysis, Share, Trend, Market Size and Forecast" was estimated to be around US$ 11.69 billion in 2019 and is anticipated to grow with 26.9% of growth rate during the future period.

This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.

COVID-19's Multifaceted Impact on Biosimilars Industry

As the COVID-19 pandemic spreads, this will continue to affect the global biopharmaceutical industry. Biosimilars are no exception, and the impact on its demand and adoption will be multifaceted. The propose report discuss three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period.

Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

  • Historical Year - 2016 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:

GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES

  • Recombinant Glycosylated Proteins
  • Recombinant Non-Glycosylated Proteins
  • Recombinant Peptides

GLOBAL BIOSIMILARS MARKET, BY APPLICATION

  • Oncology
  • Blood Disorders
  • Infectious Diseases
  • Autoimmune Diseases
  • Others

GLOBAL BIOSIMILARS MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

TABLE OF CONTENT

BIOSIMILARS MARKET OVERVIEW

  • Study Scope
  • Base Year
  • Assumption and Methodology

EXECUTIVE SUMMARY

  • Key Market Facts
  • Geographical Scenario
  • Companies in the Market

BIOSIMILARS MARKETKEY MARKET TRENDS

  • Market Drivers
  • Impact Analysis of Market Drivers
  • Market Restraints
  • Impact Analysis of Market Restraints
  • Market Opportunities
  • Market Future Trends

BIOSIMILARS MARKETINDUSTRY STUDY

  • Pipeline Therapeutic Analysis
  • Pricing Analysis
  • New Introduction by Leading Companies

BIOSIMILARS MARKET LANDSCAPE

  • Market Share Analysis
  • Key Innovators

BIOSIMILARS MARKET - BY PRODUCT TYPES:

  • Overview
  • Recombinant Glycosylated Proteins
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Recombinant Non-Glycosylated Proteins
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Recombinant Peptides
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

BIOSIMILARS MARKET - BY APPLICATION:

  • Overview
  • Oncology
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Blood Disorders
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Infectious Diseases
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Autoimmune Diseases
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Other Diseases
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

BIOSIMILARS MARKET- BY GEOGRAPHY

  • Introduction
  • North America
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • U.S.
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Canada
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Europe
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • France
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Germany
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Rest of Europe
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Asia Pacific (APAC)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • China
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • India
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Rest of APAC
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Rest of the World
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Latin America
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Middle East and Africa
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

KEY VENDOR ANALYSIS

  • Astra Zeneca, plc
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Amgen, Inc.
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Pfizer, Inc.
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Biocon Ltd.
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Novartis AG
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Teva Pharma
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • STADA AG
    • Company Overview
    • SWOT Analysis
    • Key Developments

360 DEGREE ANALYSTVIEW

APPENDIX

  • Research Methodology
  • Abbreviations
  • Disclaimer
  • Contact Us

List of Tables

  • Table 1: List of Acronyms
  • Table 2: Key Market Facts, 2014 - 2025
  • Table 3: Market Drivers: Impact Analysis
  • Table 4: Market Restraint: Impact Analysis
  • Table 5: Market Opportunity: Impact Analysis
  • Table 6: PESTLE Analysis
  • Table 7: Porter's Five Forces Analysis
  • Table 8: Company Market Share Analysis
  • Table 9: Global Biosimilars Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Figure 10: Biosimilars Market, by Product Type, 2016 - 2027 (USD Million)
  • Figure 11: Biosimilars Market, by Application, 2016 - 2027 (USD Million)
  • Figure 12: Biosimilars Market, by Geography, 2016 - 2027 (USD Million)
  • Table 13: North America Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 14: U.S. Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 15: Canada Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 16: Europe Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 17: France Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 18: Germany Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 19: Asia Pacific Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 20: China Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 21: India Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 22: Latin America Biosimilars Market, 2016 - 2027 (USD Million)
  • Table 23: MEA Biosimilars Market, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1: Research Methdology
  • Figure 2: Research Process Flow Chart
  • Figure 3: Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4: Regulatory Framework Analysis
  • Figure 5: Value Chain Analysis Analysis
  • Figure 6: Biosimilars Market, by Product Type, 2016 - 2027 (USD Million)
  • Figure 7: Biosimilars Market, by Application, 2016 - 2027 (USD Million)
  • Figure 8: Biosimilars Market, by Geography, 2016 - 2027 (USD Million)